A Type-Ii Kinase Inhibitor Capable of Inhibiting the T315I “Gatekeeper” Mutant of BCR-Abl
Journal of Medicinal Chemistry - United States
doi 10.1021/jm901808w
Full Text
Open PDFAbstract
Available in full text
Date
August 12, 2010
Authors
Publisher
American Chemical Society (ACS)